Creative Planning Mereo Biopharma Group PLC Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	BUY	$1.15 - $1.67 $18,193 - $26,419	15,820 New	15,820 $20,000
Q1 2023 May 15, 2023	BUY	$0.71 - $1.22 $8,875 - $15,250	12,500 Added 48.41%	38,320 $27,000
Q3 2022 Nov 03, 2022	BUY	$0.82 - $1.73 $21,172 - $44,668	25,820 New	25,820 $22,000
Q2 2021 Aug 04, 2021	SELL	$2.94 - $4.08 $232,756 - $323,009	-79,169 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$2.6 - $4.43 $205,839 - $350,718	79,169 New	79,169 $267,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $419M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.